Clinical Trial Update: A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated the relative bioavailability between two paliperidone 100 mg prolonged-release injectable formulations in patients with sch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PALIPERIDONE (paliperidone)

Snippet

Sponsor: Pharmathen S.A. | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED